Skip to main content

NNIT A/S: On-track performance with doubled profitability

Q3 2025 key highlightsWhile business was still being negatively impacted by macroeconomic and geopolitical uncertainty, there was an uplift in financial performance in the third quarter. Group operating profit excluding special items more than doubled at DKK 35.6m, corresponding to a margin of 8.2% against 3.9% in the third quarter of 2024. The step-change in margin development compared with last quarter and last year was driven by more efficient operations in terms of improving utilization and the effect from cost reducing initiatives carried out during 2024 and the first half of 2025. NNIT continued the momentum from late Q2 into Q3 with a solid order entry, which is a leading indicator into the fourth quarter and full-year 2026. Revenue amounted to DKK 431.6m in Q3 2025, equal to a negative revenue growth of 2.9% and organic growth...

Continue reading

Invitation to the webinar on Eesti Energia’s Q3 2025 financial results

Eesti Energia will publish its Q3 2025 financial results and interim report on 7 November. The investor call to present the results will take place on 7 November at 11:00 London time, 12:00 Frankfurt time, and 13:00 Tallinn time. The conference call will be held in English only. To participate, please join via the following link. A Q&A session will follow the presentation. As the webinar time is limited, we encourage participants to submit their questions in advance to investor@enefit.com The report and the investor call presentation will be made available in the morning of 7 November on the Eesti Energia Investor Relations website. The recording and transcript of the call will be published on the same page afterwards. Further information:Danel FreibergHead of Treasury and Financial Risk ManagementEesti Energia ASTel: +372 5594 3838Email:...

Continue reading

Q3 2025: Financial guidance for 2025 narrowed

Announcement no. 13-2025 4 November 2025 Lasse Ingemann Brodt, Group CEO of North Media, on the Group’s performance in Q3 2025:“Our Q3 2025 performance reflected a slightly lower activity level. We saw slight revenue declines in both Last Mile and Digital Services. We generated operating profit growth in Digital Services, where we reduced the losses in Dayli and Bekey by completing development projects and enhancing the efficiency of key processes. In October, we reached an important milestone in the integration of SDR into North Media as the roll-out of automated packing of printed matter for the Swedish market has now been fully completed. This creates more uniform processes across the distribution areas in Sweden and is expected to lead to costs reductions in the long term.        Financial highlights:DKKm Q3 Q3 YTD  2025 2024 2025 2024Revenue 286.4 299.4 939.2 961.4EBITDA 12.1 19.4 71.1 120.9EBIT -1.7 3.0 29.3 59.2EBIT...

Continue reading

Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

– Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months–  – Combination studies with RAS(ON) inhibitors ongoing, data anticipated 2026 – – 49% ORR and mPFS 9.1 months in histology selective cohort of multiple late line, difficult to treat cancers provide further evidence of strong activity – – $225 million in gross proceeds from October 2025 financing extends cash runway into 2028 – BOSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today reported financial results for the third quarter ended September 30, 2025, and provided business highlights. “We are wrapping up 2025 with significant momentum,...

Continue reading

Sofwave Medical Reports Third Quarter 2025 Financial Results and Business Highlights

—  Record quarterly revenue in third quarter of $21.1M, +56% year-over-year growth; IFRS gross margin of 73.7%  — Third quarter pulse recurring revenue of $8.3M, +55% year-over-year growth — First nine months revenue of $58.7M, +42% year-over-year growth; IFRS gross margin of 75.1% — First nine months IFRS and non-IFRS net income of $1.4M and $3.2M, respectively, versus a net loss of $3.8M and $2.1M, respectively, in the same year ago period — Approximately 667,00 pulse treatments administered since commercialization — Company expects to achieve net profitability in 2025 SAN CLEMENTE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the third quarter and first nine...

Continue reading

Exagen Inc. Reports Strong Q3 2025 Results

CARLSBAD, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent corporate updates.    Three Months Ended September 30,   Nine Months Ended September 30,    2025   2024   2025   2024(Unaudited, in thousands, except ASP data)    Revenue   $ 17,244     $ 12,507     $ 49,944     $ 41,986  Gross margin     58.4 %     55.8 %     59.3 %     58.7 %Operating expenses   $ 13,175     $ 11,644     $ 38,688     $ 34,888  Operating loss   $ (3,100 )   $ (4,663 )   $ (9,095 )   $ (10,253 )Net loss   $ (7,087 )   $ (5,028 )   $ (15,278 )   $ (11,354 )Adjusted EBITDA   $ (1,895 )   $ (4,024 )   $ (6,124 )   $ (7,614 )Cash and cash equivalents   $ 35,652     $ 22,035     $ 35,652     $ 22,035  Trailing-twelve-month...

Continue reading

Camposol Holding PLC’s Invitation to the Third Quarter 2025 Financial Results Presentation

Camposol Holding PLC will announce its preliminary financial results for the third quarter of 2025 on Wednesday, November 26, 2025, at 9:00 a.m. Eastern Time (ET). In connection with this release, Ricardo Naranjo Fernandez, CEO, and Jossue Yesquen Lihim, IRO, will host a conference call presentation and Q&A session. To register and participate in the conference call please use the following link: https://register-conf.media-server.com/register/BIcd23eb97c328417c99dcf2bfc1fd4b33 Participants are advised to log in to the conference call service and check their audio and system settings a few minutes before the conference call begins. To access the webcast presentation associated with the conference call, please click on the following link: https://edge.media-server.com/mmc/p/i79eb45v If you are unable to participate in the conference...

Continue reading

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended September 30, 2025 and Declaration of Distributions on Common Stock for the Months Ending January 31, February 28, and March 31, 2026

GREENWICH, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQH) (the “Company,” “we,” “us” or “our”) announced today its financial results and related information for the quarter ended September 30, 2025.On October 30, 2025, our Board of Directors declared the following distributions on our common stock:Month Ending Record Date Payment Date Amount Per ShareJanuary 31, 2026 January 16, 2026 January 30, 2026 $0.035February 28, 2026 February 13, 2026 February 27, 2026 $0.035March 31, 2026 March 17, 2026 March 31, 2026 $0.035 Net asset value (“NAV”) per share as of September 30, 2025 stood at $1.95, compared with a NAV per share on June 30, 2025 of $2.06.Net investment income (“NII”) was approximately $5.6 million, or $0.07 per share, for the...

Continue reading

Portillo’s Inc. Announces Third Quarter 2025 Financial Results

OAK BROOK, Ill., Nov. 04, 2025 (GLOBE NEWSWIRE) — Portillo’s Inc. (“Portillo’s” or the “Company”) (NASDAQ: PTLO), the one-of-a-kind restaurant concept known for its menu of Chicago-style favorites, today reported financial results for the third quarter ended September 28, 2025. Third Quarter 2025 Performance Highlights (vs. Third Quarter 2024):Total revenue of $181.4 million, an increase of 1.8% or $3.2 million Same-restaurant sales decrease of -0.8% Operating income of $5.4 million, a decrease of $10.6 million Net income of $0.8 million, a decrease of $8.0 million Restaurant-Level Adjusted EBITDA(1) of $36.7 million, a decrease of $5.3 million Adjusted EBITDA(1) of $21.4 million, a decrease of $6.5 million(1) Adjusted EBITDA and Restaurant-Level Adjusted EBITDA are non-GAAP measures. Please see definitions and the reconciliations...

Continue reading

Cohen & Company Reports Third Quarter 2025 Financial Results

Third Quarter 2025 Revenue of $84.2 Million Third Quarter 2025 Net Income Attributable to Cohen & Company Inc. of $4.6 Million, or $2.58 per Diluted Share Third Quarter 2025 Adjusted Pre-Tax Income of $16.4 Million, or $2.71 per Diluted Share Board Declares Quarterly Dividend of $0.25 per Share PHILADELPHIA and NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN), a financial services firm specializing in an expanding range of capital markets and asset management services, today reported financial results for its third quarter ended September 30, 2025. Summary Operating Results  Three Months Ended   Nine Months Ended($ in thousands) 9/30/25   6/30/25   9/30/24   9/30/25   9/30/24                   Net trading $ 13,560     $ 10,757     $ 8,816     $ 33,528     $ 27,462  Asset...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.